What Maverick Capital Ltd changed, 2013 to 2026
53 quarterly 13F filings, from Q2 2013 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.
Reported book
$11.3bn
$7.4bn at Q2 2013
Positions
179
58 at Q2 2013
Top ten weight
43%
35% at Q2 2013
Typical quarterly turnover
about 28%
Estimated from share changes
- Q2 2013: $7.4bn
- Q3 2013: $7.4bn
- Q4 2013: $7.7bn
- Q1 2014: $7.1bn
- Q2 2014: $7.0bn
- Q3 2014: $6.8bn
- Q4 2014: $6.4bn
- Q1 2015: $6.2bn
- Q2 2015: $6.6bn
- Q3 2015: $5.8bn
- Q4 2015: $6.9bn
- Q1 2016: $6.3bn
- Q2 2016: $7.4bn
- Q3 2016: $8.4bn
- Q4 2016: $7.7bn
- Q1 2017: $7.8bn
- Q2 2017: $8.0bn
- Q3 2017: $7.9bn
- Q4 2017: $7.9bn
- Q1 2018: $7.7bn
- Q2 2018: $8.6bn
- Q3 2018: $8.0bn
- Q4 2018: $6.8bn
- Q1 2019: $7.5bn
- Q2 2019: $6.9bn
- Q3 2019: $6.8bn
- Q4 2019: $6.9bn
- Q1 2020: $4.7bn
- Q2 2020: $4.8bn
- Q3 2020: $5.4bn
- Q4 2020: $6.2bn
- Q1 2021: $10.9bn
- Q2 2021: $10.6bn
- Q3 2021: $9.9bn
- Q4 2021: $8.8bn
- Q1 2022: $5.7bn
- Q2 2022: $4.1bn
- Q3 2022: $4.4bn
- Q4 2022: $4.2bn
- Q1 2023: $4.0bn
- Q2 2023: $4.7bn
- Q3 2023: $4.4bn
- Q4 2023: $5.0bn
- Q1 2024: $5.3bn
- Q2 2024: $5.3bn
- Q3 2024: $5.1bn
- Q4 2024: $5.6bn
- Q1 2025: $5.7bn
- Q2 2025: $6.7bn
- Q3 2025: $7.5bn
- Q4 2025: $9.3bn
- Q1 2026: $8.7bn
- Q2 2026: $11.3bn
- Q2 2013: 35%
- Q3 2013: 35%
- Q4 2013: 35%
- Q1 2014: 41%
- Q2 2014: 48%
- Q3 2014: 44%
- Q4 2014: 46%
- Q1 2015: 52%
- Q2 2015: 53%
- Q3 2015: 56%
- Q4 2015: 50%
- Q1 2016: 52%
- Q2 2016: 62%
- Q3 2016: 60%
- Q4 2016: 59%
- Q1 2017: 58%
- Q2 2017: 52%
- Q3 2017: 50%
- Q4 2017: 49%
- Q1 2018: 47%
- Q2 2018: 43%
- Q3 2018: 41%
- Q4 2018: 37%
- Q1 2019: 38%
- Q2 2019: 47%
- Q3 2019: 45%
- Q4 2019: 46%
- Q1 2020: 49%
- Q2 2020: 53%
- Q3 2020: 45%
- Q4 2020: 45%
- Q1 2021: 65%
- Q2 2021: 60%
- Q3 2021: 52%
- Q4 2021: 57%
- Q1 2022: 55%
- Q2 2022: 59%
- Q3 2022: 59%
- Q4 2022: 54%
- Q1 2023: 57%
- Q2 2023: 56%
- Q3 2023: 57%
- Q4 2023: 48%
- Q1 2024: 45%
- Q2 2024: 45%
- Q3 2024: 42%
- Q4 2024: 41%
- Q1 2025: 40%
- Q2 2025: 47%
- Q3 2025: 43%
- Q4 2025: 44%
- Q1 2026: 40%
- Q2 2026: 43%
The positions that defined it
Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.
| Position | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Nvidia Corp(NVDA) | Q1 2016 | $612mQ2 2026 | $612m | |
| Advanced Micro Devices Inc(AMD) | Q3 2019 | $567mQ2 2026 | $567m | |
| Astera Labs Inc(ALAB) | Q1 2024 | $515mQ2 2026 | $515m | |
| Intel Corp(INTC) | Q4 2015 | $512mQ2 2026 | $512m | |
| Alphabet Inc(GOOG)Capital Stock Class C | Q4 2015 | $510mQ2 2026 | $510m | |
| Amazon Com Inc(AMZN) | Q2 2017 | $550mQ4 2025 | $482m | |
| Nu HLDGS LTD(NU)Ordinary Shares Class A | Q1 2023 | $475mQ2 2026 | $475m | |
| Facebook Inc(META)Class A | Q3 2013 | $562mQ3 2017 | $430m | |
| GFL Environmental Inc(GFL)SUB Voting Shares | Q1 2024 | $375mQ2 2026 | $375m | |
| Natera Inc(NTRA) | Q1 2024 | $368mQ2 2026 | $368m | |
| Taiwan Semiconductor MFG LTD(TSM)Sponsored ADS | Q1 2019 | $504mQ4 2025 | $340m | |
| Dicks Sporting Goods Inc(DKS) | Q1 2019 | $334mQ2 2026 | $334m | |
| Coupang Inc(CPNG)Class A | Q1 2021 | $5.0bnQ1 2021 | Soldlast listed Q4 2025 | |
| Pfizer Inc(PFE) | Q3 2015 | $742mQ4 2016 | Soldlast listed Q3 2021 | |
| Universal HLTH SVCS Inc(UHS)Class B | Q4 2014 | $662mQ2 2017 | Soldlast listed Q2 2023 | |
| Sabre Corp(SABR) | Q2 2014 | $602mQ3 2016 | Soldlast listed Q2 2021 | |
| Priceline Com Inc | Q2 2013 | $601mQ3 2016 | Soldlast listed Q4 2017 | |
| Dollar Tree Inc(DLTR) | Q1 2015 | $569mQ2 2017 | Soldlast listed Q2 2025 | |
| Adobe Sys Inc(ADBE) | Q3 2013 | $555mQ1 2017 | Soldlast listed Q4 2025 | |
| Powershares QQQ TrustUnit Series 1 | Q2 2014 | $526mQ2 2014 | Soldlast listed Q3 2014 |
Quarter by quarter
Q2 2021: $10.6bn across 661 positions
Against Q1 2021: 229 new, 218 added to, 208 trimmed, 253 sold out, across all 661 positions.
Turnover about 14% of the book, estimated from share changes at quarter-end prices.
Largest additions
- Carvana Co (CVNA)+$94m
- Academy Sports & Outdoors In (ASO)+$55m
- Snowflake Inc (SNOW)+$51m
- Visa Inc (V)+$47m
- Alibaba Group HLDG LTD (BABA)+$30m
- Expedia Inc Del (EXPE)+$29m
- T Mobile US Inc (TMUS)+$27m
- Crown Holdings Inc (CCK)+$27m
Largest reductions
- Seer Inc (SEER)-$84m
- Applied Matls Inc (AMAT)-$83m
- Alnylam Pharmaceuticals Inc (ALNY)-$63m
- Lam Research Corp-$59m
- Aon PLC (AON)-$50m
- Amazon Com Inc (AMZN)-$43m
- LPL Finl HLDGS Inc (LPLA)-$38m
- Summit Matls Inc-$37m
Opened
- Centene Corp Del (CNC)$249m
- Jones Lang Lasalle Inc (JLL)$172m
- Cano Health Inc$96m
Sold out
- Fidelity Natl Information SV (FIS)was $63m
- Prologis Inc. (PLD)was $51m
- Elanco Animal Health Inc (ELAN)was $51m
- Thoma Bravo Advantagewas $42m
- Las Vegas Sands Corp (LVS)was $36m
- Jaws Spitfire Acquisition Cowas $31m
- Jaws Mustang Acquisition Corwas $26m
- Macerich Co (MAC)was $20m
Largest positions, Q2 2021
The largest 25 of 661 reported positions; the largest 500 carry 99.8% of the reported value.
| Position | Value | Weight | On the quarter |
|---|---|---|---|
| Coupang Inc (CPNG) | $4.5bn | 42.4% | Held |
| Microsoft Corp (MSFT) | $264m | 2.5% | Trimmed |
| Centene Corp Del (CNC) | $249m | 2.3% | New |
| Facebook Inc (META) | $236m | 2.2% | Trimmed |
| Amazon Com Inc (AMZN) | $230m | 2.2% | Trimmed |
| Alphabet Inc (GOOG) | $195m | 1.8% | Trimmed |
| Netflix Inc (NFLX) | $189m | 1.8% | Trimmed |
| Seer Inc (SEER) | $178m | 1.7% | Trimmed |
| Jones Lang Lasalle Inc (JLL) | $172m | 1.6% | New |
| T Mobile US Inc (TMUS) | $171m | 1.6% | Added |
| XP Inc (XP) | $154m | 1.4% | Added |
| Fleetcor Technologies Inc | $146m | 1.4% | Added |
| Crown Holdings Inc (CCK) | $133m | 1.3% | Added |
| 1life Healthcare Inc | $121m | 1.1% | Held |
| Atara Biotherapeutics Inc | $120m | 1.1% | Added |
| Humana Inc (HUM) | $112m | 1.1% | Trimmed |
| Lam Research Corp | $112m | 1.1% | Trimmed |
| Uber Technologies Inc (UBER) | $111m | 1.0% | Added |
| TG Therapeutics Inc (TGTX) | $109m | 1.0% | Trimmed |
| Applied Matls Inc (AMAT) | $104m | 1.0% | Trimmed |
| Alibaba Group HLDG LTD (BABA) | $102m | 1.0% | Added |
| Nektar Therapeutics | $99m | 0.9% | Trimmed |
| International Flavors&fragra (IFF) | $97m | 0.9% | Trimmed |
| Livanova PLC (LIVN) | $97m | 0.9% | Trimmed |
| Cano Health Inc | $96m | 0.9% | New |
The books most like this one
Among the managers whose filings are on file, at Q2 2026. Overlap is the share of the two books that is the same: for every stock both list, the smaller of its two weights, added up. Two books can overlap because both own the largest companies; it says nothing about whether the managers agree.
| Manager | Overlap | Stocks in both | Overlap over time | |
|---|---|---|---|---|
| Tiger Global Management LLC | 26% | 15 | Compare | |
| Capital Research Global Investors | 25% | 61 | Compare | |
| Polen Capital Management LLC | 23% | 32 | Compare | |
| Whale Rock Capital Management LLC | 23% | 21 | Compare | |
| AllianceBernstein LP | at least 22% | 67 | Compare | |
| Fidelity (FMR LLC) | at least 22% | 87 | Compare | |
| T. Rowe Price Associates Inc | at least 22% | 83 | Compare | |
| Coatue Management LLC | 22% | 19 | Compare |
“At least” where either manager has more positions than are read each quarter: a stock both hold below that range is not counted.
The filings behind it
Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.
| Quarter | Filer | Book | Amended | Filing |
|---|---|---|---|---|
| Q2 2026 | Maverick Capital Ltd | $11.3bn | 13F-HR | |
| Q1 2026 | Maverick Capital Ltd | $8.7bn | 13F-HR | |
| Q4 2025 | Maverick Capital Ltd | $9.3bn | 13F-HR | |
| Q3 2025 | Maverick Capital Ltd | $7.5bn | 13F-HR | |
| Q2 2025 | Maverick Capital Ltd | $6.7bn | 13F-HR | |
| Q1 2025 | Maverick Capital Ltd | $5.7bn | 13F-HR | |
| Q4 2024 | Maverick Capital Ltd | $5.6bn | 13F-HR | |
| Q3 2024 | Maverick Capital Ltd | $5.1bn | 13F-HR | |
| Q2 2024 | Maverick Capital Ltd | $5.3bn | 13F-HR | |
| Q1 2024 | Maverick Capital Ltd | $5.3bn | 13F-HR | |
| Q4 2023 | Maverick Capital Ltd | $5.0bn | 13F-HR | |
| Q3 2023 | Maverick Capital Ltd | $4.4bn | 13F-HR | |
| Q2 2023 | Maverick Capital Ltd | $4.7bn | 13F-HR | |
| Q1 2023 | Maverick Capital Ltd | $4.0bn | 13F-HR | |
| Q4 2022 | Maverick Capital Ltd | $4.2bn | 13F-HR | |
| Q3 2022 | Maverick Capital Ltd | $4.4bn | 13F-HR | |
| Q2 2022 | Maverick Capital Ltd | $4.1bn | 13F-HR | |
| Q1 2022 | Maverick Capital Ltd | $5.7bn | 1 | 13F-HR |
| Q4 2021 | Maverick Capital Ltd | $8.8bn | 13F-HR | |
| Q3 2021 | Maverick Capital Ltd | $9.9bn | 13F-HR | |
| Q2 2021 | Maverick Capital Ltd | $10.6bn | 13F-HR | |
| Q1 2021 | Maverick Capital Ltd | $10.9bn | 13F-HR | |
| Q4 2020 | Maverick Capital Ltd | $6.2bn | 13F-HR | |
| Q3 2020 | Maverick Capital Ltd | $5.4bn | 13F-HR | |
| Q2 2020 | Maverick Capital Ltd | $4.8bn | 13F-HR | |
| Q1 2020 | Maverick Capital Ltd | $4.7bn | 13F-HR | |
| Q4 2019 | Maverick Capital Ltd | $6.9bn | 13F-HR | |
| Q3 2019 | Maverick Capital Ltd | $6.8bn | 13F-HR | |
| Q2 2019 | Maverick Capital Ltd | $6.9bn | 13F-HR | |
| Q1 2019 | Maverick Capital Ltd | $7.5bn | 13F-HR | |
| Q4 2018 | Maverick Capital Ltd | $6.8bn | 13F-HR | |
| Q3 2018 | Maverick Capital Ltd | $8.0bn | 13F-HR | |
| Q2 2018 | Maverick Capital Ltd | $8.6bn | 13F-HR | |
| Q1 2018 | Maverick Capital Ltd | $7.7bn | 13F-HR | |
| Q4 2017 | Maverick Capital Ltd | $7.9bn | 13F-HR | |
| Q3 2017 | Maverick Capital Ltd | $7.9bn | 13F-HR | |
| Q2 2017 | Maverick Capital Ltd | $8.0bn | 13F-HR | |
| Q1 2017 | Maverick Capital Ltd | $7.8bn | 13F-HR | |
| Q4 2016 | Maverick Capital Ltd | $7.7bn | 13F-HR | |
| Q3 2016 | Maverick Capital Ltd | $8.4bn | 13F-HR | |
| Q2 2016 | Maverick Capital Ltd | $7.4bn | 13F-HR | |
| Q1 2016 | Maverick Capital Ltd | $6.3bn | 13F-HR | |
| Q4 2015 | Maverick Capital Ltd | $6.9bn | 13F-HR | |
| Q3 2015 | Maverick Capital Ltd | $5.8bn | 13F-HR | |
| Q2 2015 | Maverick Capital Ltd | $6.6bn | 13F-HR | |
| Q1 2015 | Maverick Capital Ltd | $6.2bn | 13F-HR | |
| Q4 2014 | Maverick Capital Ltd | $6.4bn | 13F-HR | |
| Q3 2014 | Maverick Capital Ltd | $6.8bn | 13F-HR | |
| Q2 2014 | Maverick Capital Ltd | $7.0bn | 13F-HR | |
| Q1 2014 | Maverick Capital Ltd | $7.1bn | 13F-HR | |
| Q4 2013 | Maverick Capital Ltd | $7.7bn | 13F-HR | |
| Q3 2013 | Maverick Capital Ltd | $7.4bn | 13F-HR | |
| Q2 2013 | Maverick Capital Ltd | $7.4bn | 13F-HR |
Reading this record
A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More